A new research commentary by Griffith University researchers explores transboundary watersheds and their impact on global biodiversity. The study identifies over 1,050 transboundary watersheds globally, with more than 70% of sediments produced in a different country than the country where they were discharged.
A glowing marker dye attached to a special marker molecule enables surgeons to visualize prostate cancer cells in real-time, allowing for more precise removal of cancerous tissues and preservation of healthy tissue. This technology has the potential to reduce the chances of cancer recurrence and minimize life-changing side effects.
Research suggests that using hearing aids can help mitigate the acceleration of brain metabolism decline in individuals with mild cognitive impairment. The study found significant annual metabolic decline in frontal cortical regions among those with untreated hearing loss, whereas those with treated hearing aids experienced no such dec...
[177Lu]Lu-PSMA-617 significantly improves radiographic progression-free survival and overall quality of life for patients with taxane-naive mCRPC, while minimizing adverse events. The study's findings suggest that [177Lu]Lu-PSMA-617 may change the treatment paradigm for pre-taxane advanced prostate cancer patients.
Dr. George Sgouros has been recognized for his outstanding contributions to the field of nuclear medicine, with a focus on calculating precise radiation dosages for cancer patients. His research aims to maximize treatment benefits and minimize side effects through targeted alpha-emitter therapy.
Researchers have found that turbulence is most suppressed at a certain density in fusion plasmas, with transitions occurring below and above this point. Simulations revealed that ion-temperature gradient, pressure gradient, and plasma resistivity cause turbulence changes around the transition density.
Carolyn J. Anderson has made significant contributions to the development of radiometal-based agents for diagnostic imaging and targeted radionuclide therapy of cancer, a field known as 'theranostics.' Her work led to the FDA approval of Lu-177 DOTATATE for treating neuroendocrine tumors.
A multi-center study found that healthy older adults with beta-amyloid deposits showed significantly less training improvement in cognitive tasks. However, individuals without amyloid deposits demonstrated better cognitive plasticity and training effectiveness.
A novel imaging approach, Ga-DOTATATE PET/CT, offers enhanced sensitivity and specificity for detecting residual/recurrent tumors in patients with head and neck paragangliomas. This method improves the differentiation between tumor and scar tissue post-surgery.
Cybil Nielsen has been elected as the 2024-25 president-elect of the Society of Nuclear Medicine and Molecular Imaging Technologist Section. She aims to expand educational programs, mentorship opportunities, and networking events to facilitate continuous learning and career advancement among members.
Julie Dawn Bolin, a seasoned nuclear medicine technologist and educator, has been elected as the new president of the SNMMI Technologist Section for 2024-25. Bolin aims to advance the field by bolstering educational initiatives, championing advocacy efforts, and promoting access to education and healthcare in marginalized communities.